Literature DB >> 16775514

Cognitive and adaptive behavior profiles in Smith-Magenis syndrome.

Niru Madduri1, Sarika U Peters, Robert G Voigt, Antolin M Llorente, James R Lupski, Lorraine Potocki.   

Abstract

Smith-Magenis syndrome (SMS) is a multiple congenital anomalies and mental retardation syndrome associated with an interstitial deletion of chromosome 17 band p11.2. The incidence of this microdeletion syndrome is estimated to be 1 in 25,000 individuals. Persons with SMS have a distinctive neurobehavioral phenotype that is characterized by aggressive and self-injurious behaviors and significant sleep disturbances. From December 1990 through September 1999, 58 persons with SMS were enrolled in a 5-day multidisciplinary clinical protocol. Developmental assessments consisting of cognitive level and adaptive behavior were completed in 57 persons. Most patients functioned in the mild-to-moderate range of mental retardation. In addition, we report that patients with SMS have low adaptive functioning with relative strengths in socialization and relative weakness in daily living skills. These data were analyzed in light of the molecular extent of the microdeletion within 17p11.2. We found that the level of cognitive and adaptive functioning does depend on deletion size, and that a small percentage of SMS patients have cognitive function in the borderline range.

Entities:  

Mesh:

Year:  2006        PMID: 16775514     DOI: 10.1097/00004703-200606000-00002

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  17 in total

Review 1.  Neurodevelopmental Disorders Associated with Abnormal Gene Dosage: Smith-Magenis and Potocki-Lupski Syndromes.

Authors:  Juanita Neira-Fresneda; Lorraine Potocki
Journal:  J Pediatr Genet       Date:  2015-09-28

2.  Characterization of Potocki-Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype.

Authors:  Lorraine Potocki; Weimin Bi; Diane Treadwell-Deering; Claudia M B Carvalho; Anna Eifert; Ellen M Friedman; Daniel Glaze; Kevin Krull; Jennifer A Lee; Richard Alan Lewis; Roberto Mendoza-Londono; Patricia Robbins-Furman; Chad Shaw; Xin Shi; George Weissenberger; Marjorie Withers; Svetlana A Yatsenko; Elaine H Zackai; Pawel Stankiewicz; James R Lupski
Journal:  Am J Hum Genet       Date:  2007-02-26       Impact factor: 11.025

3.  Reciprocal deletion and duplication of 17p11.2-11.2: Korean patients with Smith-Magenis syndrome and Potocki-Lupski syndrome.

Authors:  Cha Gon Lee; Sang-Jin Park; Jun-No Yun; Shin-Young Yim; Young Bae Sohn
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

4.  Functional and cellular characterization of human Retinoic Acid Induced 1 (RAI1) mutations associated with Smith-Magenis Syndrome.

Authors:  Paulina Carmona-Mora; Carolina A Encina; Cesar P Canales; Lei Cao; Jessica Molina; Pamela Kairath; Juan I Young; Katherina Walz
Journal:  BMC Mol Biol       Date:  2010-08-25       Impact factor: 2.946

5.  Review of disrupted sleep patterns in Smith-Magenis syndrome and normal melatonin secretion in a patient with an atypical interstitial 17p11.2 deletion.

Authors:  Eilis A Boudreau; Kyle P Johnson; Angela R Jackman; Jan Blancato; Marjan Huizing; Claude Bendavid; Marypat Jones; Settara C Chandrasekharappa; Alfred J Lewy; Ann C M Smith; R Ellen Magenis
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

6.  Neurodevelopment of children under 3 years of age with Smith-Magenis syndrome.

Authors:  Pamela L Wolters; Andrea L Gropman; Staci C Martin; Michaele R Smith; Hanna L Hildenbrand; Carmen C Brewer; Ann C M Smith
Journal:  Pediatr Neurol       Date:  2009-10       Impact factor: 3.372

Review 7.  A cross-comparison of cognitive ability across 8 genomic disorders.

Authors:  Michael Mortillo; Jennifer G Mulle
Journal:  Curr Opin Genet Dev       Date:  2021-05-31       Impact factor: 4.665

8.  Mouse models of genomic syndromes as tools for understanding the basis of complex traits: an example with the smith-magenis and the potocki-lupski syndromes.

Authors:  P Carmona-Mora; J Molina; C A Encina; K Walz
Journal:  Curr Genomics       Date:  2009-06       Impact factor: 2.236

9.  Behavioral disturbance and treatment strategies in Smith-Magenis syndrome.

Authors:  Alice Poisson; Alain Nicolas; Pierre Cochat; Damien Sanlaville; Caroline Rigard; Hélène de Leersnyder; Patricia Franco; Vincent Des Portes; Patrick Edery; Caroline Demily
Journal:  Orphanet J Rare Dis       Date:  2015-09-04       Impact factor: 4.123

Review 10.  Major influence of repetitive elements on disease-associated copy number variants (CNVs).

Authors:  Ana R Cardoso; Manuela Oliveira; Antonio Amorim; Luisa Azevedo
Journal:  Hum Genomics       Date:  2016-09-23       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.